𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of second breast cancer according to estrogen receptor status and family history

✍ Scribed by Christine Bouchardy; Simone Benhamou; Gérald Fioretta; Helena M. Verkooijen; Pierre O. Chappuis; Isabelle Neyroud-Caspar; Monica Castiglione; Vincent Vinh-Hung; Georges Vlastos; Elisabetta Rapiti

Publisher
Springer US
Year
2010
Tongue
English
Weight
181 KB
Volume
127
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Body-size indicators and risk of breast
Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status
✍ Satu Männistö; Pirjo Pietinen; Marjo Pyy; Juni Palmgren; Matti Eskelinen; Matti 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 597 KB

Associations between the risk of breast cancer and body-size indicators at the time of breast-cancer diagnosis were assessed among 328 pre-menopausal or post-menopausal cases and 4 I7 controls participating in the Kuopio Breast Cancer Study. This case-control study follows the protocol of the intern

Risk factors according to estrogen recep
Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India
✍ Subhojit Dey; Paolo Boffetta; Anitha Mathews; Paul Brennan; Amr Soliman; Aleyamm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 1 views

## Abstract Estrogen receptor (ER) status is an important biomarker in defining subtypes of breast cancer differing in antihormonal therapy response, risk factors and prognosis. However, little is known about association of ER status with various risk factors in the developing world. Our case–contr

Association between family history of ca
Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status
✍ Angela M. Tutera; Thomas A. Sellers; John D. Potter; Carol R. Drinkard; Georgia 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

There are recent data to suggest that risk factors for breast cancer may differ according to whether the tumor expresses detectable levels of the estrogen receptor (ER) and progesterone receptor (PR). While a family history of breast cancer is one of the most consistent predictors of the disease, we